Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  44,018 results for ""Hepatocellular carcinoma""

Your Filters

Publisher : biomed central
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review.

  • Authors : Xie GL; Department of Hepatobiliary Surgery, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, China.; Zhong ZH

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/therapy

  • Source: BMC surgery [BMC Surg] 2025 Jan 29; Vol. 25 (1), pp. 47. Date of Electronic Publication: 2025 Jan 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968567 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation.

  • Authors : Li C; Department of Radiation Oncology, Peking University Third Hospital, Beijing, 100191, China. .; Xiong L

Subjects: Sorafenib*/Sorafenib*/Sorafenib*/pharmacology ; PPAR alpha*/PPAR alpha*/PPAR alpha*/metabolism ; PPAR alpha*/PPAR alpha*/PPAR alpha*/genetics

  • Source: Molecular cancer [Mol Cancer] 2025 Jan 28; Vol. 24 (1), pp. 34. Date of Electronic Publication: 2025 Jan 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium:

Record details

Connect Read More Add to Saved list
×
Academic Journal

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis.

  • Authors : Zhang Y; State Key Laboratory of Traditional Chinese Medicine Syndrome/The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.; Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/genetics ; Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics

  • Source: Molecular cancer [Mol Cancer] 2025 Jan 27; Vol. 24 (1), pp. 32. Date of Electronic Publication: 2025 Jan 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium:

Record details

Connect Read More Add to Saved list
×
Academic Journal

Artificial intelligence-assisted platform performs high detection ability of hepatocellular carcinoma in CT images: an external clinical validation study.

  • Authors : Shan R; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.; Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 271099, China.

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/diagnostic imaging ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnostic imaging

  • Source: BMC cancer [BMC Cancer] 2025 Jan 27; Vol. 25 (1), pp. 154. Date of Electronic Publication: 2025 Jan 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

Record details

Connect Read More Add to Saved list
×
Academic Journal

Three effective cases of transcatheter arterial embolization after atezolizumab and bevacizumab treatment for hepatocellular carcinoma: a case report.

  • Authors : Rinka K; Department of Hepatology, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori Miyakojima-Ku, Osaka, 534-0021, Japan. .; Kioka K

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy

  • Source: Journal of medical case reports [J Med Case Rep] 2025 Jan 27; Vol. 19 (1), pp. 38. Date of Electronic Publication: 2025 Jan 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Essential oils from Amorpha fruticosa against hepatocellular carcinoma based on network pharmacology.

  • Authors : Liu Y; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Zhang X

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Oils, Volatile*/Oils, Volatile*/Oils, Volatile*/pharmacology ; Oils, Volatile*/Oils, Volatile*/Oils, Volatile*/chemistry

  • Source: BMC complementary medicine and therapies [BMC Complement Med Ther] 2025 Jan 27; Vol. 25 (1), pp. 29. Date of Electronic Publication: 2025 Jan 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101761232 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma.

  • Authors : Wu HY; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu, 210029, People's Republic of China.; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, People's Republic of China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy

  • Source: BMC cancer [BMC Cancer] 2025 Jan 23; Vol. 25 (1), pp. 131. Date of Electronic Publication: 2025 Jan 23.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

3D synergistic tumor-liver analysis further improves the efficacy prediction in hepatocellular carcinoma: a multi-center study.

  • Authors : Jiang Y; Department of Radiology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People's Hospital, The Affiliated Hospital of Beijing Institute of Technology), No. 79 Kangning Road, Zhuhai, 519000, Guangdong Province, China.; Zhuhai Interventional Medical Center, Zhuhai People's Hospital, The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University, No. 79 Kangning Road, Zhuhai, 519000, Guangdong Province, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnosis

  • Source: BMC cancer [BMC Cancer] 2025 Jan 21; Vol. 25 (1), pp. 108. Date of Electronic Publication: 2025 Jan 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

Record details

Connect Read More Add to Saved list
×
Academic Journal

A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers.

  • Authors : Zeng Q; Department of Clinical Laboratory Medicine, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Zhou Z

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/blood Folfox protocol

  • Source: BMC cancer [BMC Cancer] 2025 Jan 21; Vol. 25 (1), pp. 112. Date of Electronic Publication: 2025 Jan 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

Record details

Connect Read More Add to Saved list
×
Academic Journal

TGF-β signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: unveiling insights and clinical significance.

  • Authors : Ge J; Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, China.; Jiangsu Engineering Research Center for Tumor Immunotherapy, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, China.

Subjects: Tumor Microenvironment* ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: BMC cancer [BMC Cancer] 2025 Jan 21; Vol. 25 (1), pp. 113. Date of Electronic Publication: 2025 Jan 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

Record details

Connect Read More Add to Saved list
×
  • 1-10 of  44,018 results for ""Hepatocellular carcinoma""